Neomycinum Tzf (Neomycin Sulfate)

Neomycin Sulfate, the active ingredient in Neomycinum Tzf, is an aminoglycoside antibiotic presented as a topical preparation for skin use. It treats superficial bacterial skin infections in both adults and children. GNH USA supplies Neomycinum Tzf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neomycinum Tzf is a topical aminoglycoside used to manage bacterial skin conditions. - Impetigo: reduces bacterial load and promotes healing of infected lesions. - Minor cuts and abrasions: prevents bacterial colonisation and supports wound closure. - Superficial burns: limits infection risk and aids tissue recovery. - Infected eczema: controls secondary bacterial infection and alleviates inflammation. - Folliculitis: eradicates causative bacteria and reduces pustule formation.

Topical application of Neomycinum Tzf may cause local reactions.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: localized pruritus following use. - Burning sensation: transient warmth or stinging. - Dryness: reduced skin moisture. - Contact dermatitis: eczematous rash in sensitive individuals. - Hyperpigmentation: temporary darkening of treated skin.

Serious or Rare Side Effects: - Allergic reaction: urticaria, angioedema, or anaphylaxis. - Stevens‑Johnson syndrome: severe mucocutaneous blistering. - Toxic epidermal necrolysis: extensive skin detachment. - Systemic toxicity: rare nephrotoxicity or ototoxicity if absorbed in large amounts. - Severe contact dermatitis: intense inflammation requiring medical attention. - Delayed wound healing: prolonged infection due to resistance.

When using Neomycinum Tzf, consider the following safety measures. - Allergy assessment: avoid use in patients with known hypersensitivity to neomycin or other aminoglycosides. - Pregnancy and lactation: consult a healthcare professional before application. - Extent of application: limit to small areas to minimise systemic absorption. - Duration of therapy: discontinue once infection resolves or after the prescribed period. - Storage: Store at below 25°C: keep in the original container, protect from moisture and light.

Neomycinum Tzf may interact with other medicines or topical agents.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of nephro‑ or ototoxicity. - Other topical antibiotics: combined use can heighten local irritation. - Silver‑containing dressings: may reduce antibacterial efficacy.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection, requiring close observation. - Antiseptic solutions (e.g., chlorhexidine): could alter drug absorption. - Occlusive dressings: may increase local drug concentration and irritation.